Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone effects on extracellular adenosine formation in healthy volunteers
NL-OMON38928Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of eplerenone in ischemia-reperfusion injury (IRI) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Effect of eplerenone on extracellular adenosine formation assessed by dipyridamole-induced forearm vasodilation. Started Apr 2013; status: active, not recruiting.
02
Drugs
eplerenone
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NL-OMON38928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38928.